Varda is solving an unusual problem: gravity, and its effects on drugmaking. The startup builds small spacecraft that process pharmaceutical materials in orbit and then brings them back down to Earth. The lack of gravity allows for new drug combinations that would not be possible to manufacture on Earth.
Natural Capital and Shrug VC led the Series C funding round, the company said. Previous investors including
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.
